Dyne Therapeutics Prices Upsized $375 Million Public Offering at $20.50 per Share
Dyne Therapeutics has priced an upsized public offering of 18.3 million shares at $20.50 each, generating expected gross proceeds of approximately $375.15 million before fees and expenses.
Tickers: $DYN